Latest News
Cytokinetics Releases Update on Phase 1 Trial at Annual SMA Conference
At last week’s Annual SMA Conference, Cytokinetics released additional data from their Phase 1 study of CK-2127107, a skeletal muscle activator. Cytokinetics, in partnership with Astellas, has already announced that […]
Read More ›Isis Announces Additional Trial Results at Annual SMA Conference
At last week’s Annual SMA Conference, Isis Pharmaceuticals, Inc. provided an update on children with spinal muscular atrophy (SMA) who have completed the open-label, Phase 2 multiple-dose study of ISIS-SMNRx […]
Read More ›Cure SMA Announces Nearly $2 Million in New Planned Research Funding
Cure SMA has announced plans to fund $1.995 million in new research grants over the next several months. This includes funding for all four areas of our research model—basic research, […]
Read More ›Dr. Mary Schroth Joins Cure SMA as Medical Professional Education Consultant
We are very excited to announce that Dr. Mary Schroth has joined us as our medical professional education consultant. She will be working with us a few days each month, […]
Read More ›Read the Summer 2015 Issue of Compass
The latest issue of Compass, our research publication, is now available online. This summer 2015 issue includes information on our recent drug discovery grants, plus an update to our SMA […]
Read More ›The 2015 Annual SMA Conference is Here!
The 26th Annual SMA Conference kicks off tomorrow with our Newly Diagnosed Program, and continues into the weekend with all of our usual programs that bring families, researchers, and healthcare […]
Read More ›